• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

VNLPY:US

1.0440 USD 0.0440 4.40%

As of 20:10:00 ET on 06/30/2014.

Snapshot for Vernalis PLC (VNLPY)

Open: 1.0440 Day's Range: 1.0440 - 1.0440 Volume: 1,000
Previous Close: 1.0000 52wk Range: 0.6639 - 1.3600 1-Yr Rtn: -

Stock Chart for VNLPY

No chart data available.
  • VNLPY:US 1.0440
  • 1D
  • 1M
  • 1Y
1.0000
Interactive VNLPY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for VNLPY

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (12/2014) -0.0410
Est. PEG Ratio -
Market Cap (M USD) 230.86
Shares Outstanding (M) 221.13
30 Day Average Volume 120
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 48.0400
Dividend Ex-Date 07/08/1996
5 Year Dividend Growth -
Next Earnings Announcement 08/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for VNLPY

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for VNLPY

Vernalis plc is a revenue generating development stage pharmaceutical company which has a broad pipeline of research and development programs. The Company is focused on developing products for the US prescription cough and cold market. The Company derives pipeline candidates both from collaborations with global pharmaceutical businesses and their own research activities.

Ian GarlandChief Executive OfficerDavid MackneyChief Financial Officer
Kevin KissaneSecretary
More Company Profile & Key Executives for VNLPY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil